Author:
Giiang Lung-Hui,Liu Chang-Hsien,Yu Chih-Yung,Lin Te-Pao,Chen Hsiang-Cheng,Juan Chun-Jung,Chou Yu-Ching
Funder
Tri-Service General Hospital
Publisher
Springer Science and Business Media LLC
Subject
Biomedical Engineering,General Medicine
Reference13 articles.
1. Hong, S. N., Lee, S. Y., Choi, M. S., Lee, J. H., Koh, K. C., Paik, S. W., Yoo, B. C., Rhee, J. C., Choi, D., Lim, H. K., Lee, K. W., & Joh, J. W. (2005). Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. Journal of Clinical Gastroenterology, 39(3), 247–252. https://doi.org/10.1097/01.mcg.0000152746.72149.31.
2. Vivarelli, M., Guglielmi, A., Ruzzenente, A., Cucchetti, A., Bellusci, R., Cordiano, C., & Cavallari, A. (2004). Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Annals of Surgery, 240(1), 102–107. https://doi.org/10.1097/01.sla.0000129672.51886.44.
3. Chiou, Y. Y., Chou, Y. H., Chiang, J. H., Wang, H. K., & Chang, C. Y. (2005). Percutaneous ultrasound-guided radiofrequency ablation of colorectal liver metastases. Chinese Journal of Radiology, 30(3), 153–158.
4. Raoul, J. L., Sangro, B., Forner, A., Mazzaferro, V., Piscaglia, F., Bolondi, L., & Lencioni, R. (2011). Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization. Cancer Treatment Reviews, 37(3), 212–220. https://doi.org/10.1016/j.ctrv.2010.07.006.
5. Sieghart, W., Hucke, F., & Peck-Radosavljevic, M. (2015). Transarterial chemoembolization: Modalities, indication, and patient selection. Journal of Hepatology, 62(5), 1187–1195. https://doi.org/10.1016/j.jhep.2015.02.010.